Clinical Trial Update: TAB08 in Patients With Systemic Lupus Erythematosus (SLE), Not Adequately Controlled With Current Treatment [Phase 2]

View source ↗

Summary

A Phase 2 trial of TAB08 in patients with systemic lupus erythematosus not adequately controlled on current therapy was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Erythematosus Systemic

Drugs mentioned

• TAB08

Snippet

Sponsor: Theramab LLC | Conditions: Lupus Erythematosus, Systemic | Phase 2 | Status: TERMINATED